Andhrapradesh Journal

Biopharmaceuticals Market Projected to Grasp $526,008 Million by 2025 With a CAGR 13.8% – Allied Market Research

 Breaking News
  • No posts were found

Biopharmaceuticals Market Projected to Grasp $526,008 Million by 2025 With a CAGR 13.8% – Allied Market Research

November 30
18:54 2019
Biopharmaceuticals Market Projected to Grasp $526,008 Million by 2025 With a CAGR 13.8% - Allied Market Research

Biopharmaceuticals Market
Pharmaceutical companies have streamlined drug discovery and development through adoption of biopharmaceuticals. Biopharmaceuticals and therapeutic proteins have immensely aided in target-based treatment for chronic diseases, especially cancer

According to a new report released by Allied Market Research, according to “Biopharmaceutical market by type and application: Global opportunity analysis and industry forecast, 2018-2025”, the market is $186,470 million in 2017, and is anticipated to hit $526,008 million In 2025, the growth rate is 13.8% CAGR from 2018 to 2025. North America is expected to be the highest revenue contributor throughout the forecast period.

Biopharmaceuticals, also known as biologics, are drugs that are manufactured in living systems, such as microorganisms and animal cells. An array of different biopharmaceuticals is also produced using recombinant DNA technology. The biopharmaceuticals sector is the fastest-growing segment of the pharmaceutical industry.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/3971

The global biopharmaceuticals market is anticipated to grow considerably in the near future, owing to various factors, such as strategic collaborations among biopharmaceuticals companies, increase in obesity and sedentary lifestyle among the population, rise in elderly population, and upsurge in prevalence of chronic diseases, such as cancer, globally. However, high costs associated with biopharmaceuticals drug development and a stringent regulatory scenario are key factors expected to impede the market growth. On the contrary, emerging markets, such as India and China, are anticipated to provide lucrative growth opportunities to the market players during the forecast period.

By type, the monoclonal antibody segment accounted for nearly two-fifths share of the global biopharmaceuticals market in 2017. In terms of application, the oncology segment accounted for one-third share in 2017, and is projected to exhibit a prominent growth rate, owing to surge in cancer prevalence globally. By region, North America generated the highest revenue in the global biopharmaceuticals market in 2017.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/3971

KEY FINDINGS OF THE STUDY 

  • The monoclonal antibody segment is anticipated to dominate the global biopharmaceuticals market from 2018 to 2025.
  • The metabolic disease application is anticipated to grow with the highest CAGR throughout the forecast period.
  • North America accounted for a share of more than two-fifths of the global biopharmaceuticals market in 2017.
  • The Asia-Pacific region is anticipated to grow at the highest rate in the global biopharmaceuticals market during the forecast period, followed by LAMEA.

 

North America held the highest market share in 2017, owing to high prevalence rate of cancer and other chronic diseases, adoption of biologics, and increase in awareness about biopharmaceuticals. The Asia-Pacific region is expected to grow at the highest CAGR of 17.2% during the forecast period, owing to rapid industrialization in the area, increase in disposable income, and upsurge in government initiatives to modernize the healthcare infrastructure.

The report provides an extensive competitive analysis and profiles of the key market players, such as Abbott Laboratories, Amgen, Inc., Biogen, Inc., Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Pfizer, Inc., and Sanofi. The other players in the value chain (not included in the report) include Bristol Myers Squibb Company, Bayer AG, and Shire plc.

Similar Reports: 

Biosimilars Market – Global Opportunity Analysis and Industry Forecast, 2014-2020

Spine Biologics Market – Global Opportunity Analysis and Industry Forecast, 2014-2022

About Us 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Media Contact
Company Name: Allied Market Research
Contact Person: David Correa
Email: Send Email
Phone: +1-800-792-5285
Address:5933 NE Win Sivers Drive #205
City: Portland
State: OR 97220
Country: United States
Website: www.alliedmarketresearch.com/biopharmaceutical-market

Related Articles